Clinical trial
Efficacy of Calprotectin as A Marker For the Pathogenicity of Blastocystis Infection
NCT05724368 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Calprotectin as A Marker For the Pathogenicity of Blastocystis Infection
- Lead sponsor
- Sohag University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2023
- Completion date
- March 31, 2025
- Enrollment
- 150 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.